Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

NCT03583710 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

ENSAT Stage I Adrenal Cortex Carcinoma
ENSAT Stage II Adrenal Cortex Carcinoma
ENSAT Stage III Adrenal Cortex Carcinoma

Interventions

DRUG: Cisplatin
DRUG: Etoposide
DRUG: Mitotane
OTHER: Quality-of-Life Assessment

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]